Conference - Boston, MA, United States
According to the Centers for Disease Control and Prevention, antibiotic-resistant infections are associated with an additional 23,000 deaths and 2 million illnesses in the United States each year. The estimated annual impact of antibiotic-resistant infections on the national economy is $20 billion in excess direct health care costs, and as much as $35 billion in lost productivity from hospitalizations and sick days. By holding the Re-Entering Antibacterial Drug Development Summit, we at Cambridge Healthtech Institute are trying to contribute to the efforts to revive antibacterial pipeline, and to improve antimicrobial stewardship in the United States and worldwide. This Summit is designed as a forum for knowledge and opinion exchange between the major stakeholders, who are shaping the current state of antibacterial discovery and development.
Sponsoring Institutions: Cambridge Healthtech Institute
For more information, please visit: http://www.healthtech.com/
November 16-18, 2015
Hilton Boston Back Bay
Boston, MA 02210, United States
Contact: Marina Filshtinsky (chi@healthtech.com)
Contact: 7819725400
